世界の女性用避妊薬市場規模・現状・予測2021-2027

【英語タイトル】Global Female Contraceptives Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR2330)・商品コード:QY21APR2330
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、女性用避妊薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(避妊薬、避妊具)、用途別市場規模(個人用、病院)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・女性用避妊薬の市場動向
・企業の競争状況、市場シェア
・女性用避妊薬の種類別市場規模(避妊薬、避妊具)
・女性用避妊薬の用途別市場規模(個人用、病院)
・女性用避妊薬の北米市場規模2016-2027(アメリカ、カナダ)
・女性用避妊薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・女性用避妊薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・女性用避妊薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・女性用避妊薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bayer、Mayer Laboratories、Pfizer、Mylan、Teva、Merck、Johnson & Johnson、Lupin Pharmaceuticals、Female Health Company、Fuji Latex)
・結論
【レポートの概要】

Market Analysis and Insights: Global Female Contraceptives Market
The global Female Contraceptives market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Female Contraceptives market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Female Contraceptives market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Female Contraceptives market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Female Contraceptives market.

Global Female Contraceptives Scope and Market Size
Female Contraceptives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraceptives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Contraceptive Drugs
Contraceptive Devices

Segment by Application
Personal use
Hospital

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Contraceptives Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Contraceptive Drugs
1.2.3 Contraceptive Devices
1.3 Market by Application
1.3.1 Global Female Contraceptives Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Personal use
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Female Contraceptives Market Perspective (2016-2027)
2.2 Female Contraceptives Growth Trends by Regions
2.2.1 Female Contraceptives Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Female Contraceptives Historic Market Share by Regions (2016-2021)
2.2.3 Female Contraceptives Forecasted Market Size by Regions (2022-2027)
2.3 Female Contraceptives Industry Dynamic
2.3.1 Female Contraceptives Market Trends
2.3.2 Female Contraceptives Market Drivers
2.3.3 Female Contraceptives Market Challenges
2.3.4 Female Contraceptives Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Female Contraceptives Players by Revenue
3.1.1 Global Top Female Contraceptives Players by Revenue (2016-2021)
3.1.2 Global Female Contraceptives Revenue Market Share by Players (2016-2021)
3.2 Global Female Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Female Contraceptives Revenue
3.4 Global Female Contraceptives Market Concentration Ratio
3.4.1 Global Female Contraceptives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Contraceptives Revenue in 2020
3.5 Female Contraceptives Key Players Head office and Area Served
3.6 Key Players Female Contraceptives Product Solution and Service
3.7 Date of Enter into Female Contraceptives Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Female Contraceptives Breakdown Data by Type
4.1 Global Female Contraceptives Historic Market Size by Type (2016-2021)
4.2 Global Female Contraceptives Forecasted Market Size by Type (2022-2027)

5 Female Contraceptives Breakdown Data by Application
5.1 Global Female Contraceptives Historic Market Size by Application (2016-2021)
5.2 Global Female Contraceptives Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Female Contraceptives Market Size (2016-2027)
6.2 North America Female Contraceptives Market Size by Type
6.2.1 North America Female Contraceptives Market Size by Type (2016-2021)
6.2.2 North America Female Contraceptives Market Size by Type (2022-2027)
6.2.3 North America Female Contraceptives Market Size by Type (2016-2027)
6.3 North America Female Contraceptives Market Size by Application
6.3.1 North America Female Contraceptives Market Size by Application (2016-2021)
6.3.2 North America Female Contraceptives Market Size by Application (2022-2027)
6.3.3 North America Female Contraceptives Market Size by Application (2016-2027)
6.4 North America Female Contraceptives Market Size by Country
6.4.1 North America Female Contraceptives Market Size by Country (2016-2021)
6.4.2 North America Female Contraceptives Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Female Contraceptives Market Size (2016-2027)
7.2 Europe Female Contraceptives Market Size by Type
7.2.1 Europe Female Contraceptives Market Size by Type (2016-2021)
7.2.2 Europe Female Contraceptives Market Size by Type (2022-2027)
7.2.3 Europe Female Contraceptives Market Size by Type (2016-2027)
7.3 Europe Female Contraceptives Market Size by Application
7.3.1 Europe Female Contraceptives Market Size by Application (2016-2021)
7.3.2 Europe Female Contraceptives Market Size by Application (2022-2027)
7.3.3 Europe Female Contraceptives Market Size by Application (2016-2027)
7.4 Europe Female Contraceptives Market Size by Country
7.4.1 Europe Female Contraceptives Market Size by Country (2016-2021)
7.4.2 Europe Female Contraceptives Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Female Contraceptives Market Size (2016-2027)
8.2 Asia-Pacific Female Contraceptives Market Size by Type
8.2.1 Asia-Pacific Female Contraceptives Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Female Contraceptives Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Female Contraceptives Market Size by Type (2016-2027)
8.3 Asia-Pacific Female Contraceptives Market Size by Application
8.3.1 Asia-Pacific Female Contraceptives Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Female Contraceptives Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Female Contraceptives Market Size by Application (2016-2027)
8.4 Asia-Pacific Female Contraceptives Market Size by Region
8.4.1 Asia-Pacific Female Contraceptives Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Female Contraceptives Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Female Contraceptives Market Size (2016-2027)
9.2 Latin America Female Contraceptives Market Size by Type
9.2.1 Latin America Female Contraceptives Market Size by Type (2016-2021)
9.2.2 Latin America Female Contraceptives Market Size by Type (2022-2027)
9.2.3 Latin America Female Contraceptives Market Size by Type (2016-2027)
9.3 Latin America Female Contraceptives Market Size by Application
9.3.1 Latin America Female Contraceptives Market Size by Application (2016-2021)
9.3.2 Latin America Female Contraceptives Market Size by Application (2022-2027)
9.3.3 Latin America Female Contraceptives Market Size by Application (2016-2027)
9.4 Latin America Female Contraceptives Market Size by Country
9.4.1 Latin America Female Contraceptives Market Size by Country (2016-2021)
9.4.2 Latin America Female Contraceptives Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Female Contraceptives Market Size (2016-2027)
10.2 Middle East & Africa Female Contraceptives Market Size by Type
10.2.1 Middle East & Africa Female Contraceptives Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Female Contraceptives Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Female Contraceptives Market Size by Type (2016-2027)
10.3 Middle East & Africa Female Contraceptives Market Size by Application
10.3.1 Middle East & Africa Female Contraceptives Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Female Contraceptives Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Female Contraceptives Market Size by Application (2016-2027)
10.4 Middle East & Africa Female Contraceptives Market Size by Country
10.4.1 Middle East & Africa Female Contraceptives Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Female Contraceptives Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Female Contraceptives Introduction
11.1.4 Bayer Revenue in Female Contraceptives Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Mayer Laboratories
11.2.1 Mayer Laboratories Company Details
11.2.2 Mayer Laboratories Business Overview
11.2.3 Mayer Laboratories Female Contraceptives Introduction
11.2.4 Mayer Laboratories Revenue in Female Contraceptives Business (2016-2021)
11.2.5 Mayer Laboratories Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Female Contraceptives Introduction
11.3.4 Pfizer Revenue in Female Contraceptives Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Female Contraceptives Introduction
11.4.4 Mylan Revenue in Female Contraceptives Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Female Contraceptives Introduction
11.5.4 Teva Revenue in Female Contraceptives Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Female Contraceptives Introduction
11.6.4 Merck Revenue in Female Contraceptives Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Female Contraceptives Introduction
11.7.4 Johnson & Johnson Revenue in Female Contraceptives Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Details
11.8.2 Lupin Pharmaceuticals Business Overview
11.8.3 Lupin Pharmaceuticals Female Contraceptives Introduction
11.8.4 Lupin Pharmaceuticals Revenue in Female Contraceptives Business (2016-2021)
11.8.5 Lupin Pharmaceuticals Recent Development
11.9 Female Health Company
11.9.1 Female Health Company Company Details
11.9.2 Female Health Company Business Overview
11.9.3 Female Health Company Female Contraceptives Introduction
11.9.4 Female Health Company Revenue in Female Contraceptives Business (2016-2021)
11.9.5 Female Health Company Recent Development
11.10 Fuji Latex
11.10.1 Fuji Latex Company Details
11.10.2 Fuji Latex Business Overview
11.10.3 Fuji Latex Female Contraceptives Introduction
11.10.4 Fuji Latex Revenue in Female Contraceptives Business (2016-2021)
11.10.5 Fuji Latex Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Female Contraceptives Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Contraceptive Drugs
Table 3. Key Players of Contraceptive Devices
Table 4. Global Female Contraceptives Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Female Contraceptives Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Female Contraceptives Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Female Contraceptives Market Share by Regions (2016-2021)
Table 8. Global Female Contraceptives Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Female Contraceptives Market Share by Regions (2022-2027)
Table 10. Female Contraceptives Market Trends
Table 11. Female Contraceptives Market Drivers
Table 12. Female Contraceptives Market Challenges
Table 13. Female Contraceptives Market Restraints
Table 14. Global Female Contraceptives Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Female Contraceptives Market Share by Players (2016-2021)
Table 16. Global Top Female Contraceptives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Contraceptives as of 2020)
Table 17. Ranking of Global Top Female Contraceptives Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Female Contraceptives Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Female Contraceptives Product Solution and Service
Table 21. Date of Enter into Female Contraceptives Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Female Contraceptives Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Female Contraceptives Revenue Market Share by Type (2016-2021)
Table 25. Global Female Contraceptives Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Female Contraceptives Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Female Contraceptives Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Female Contraceptives Revenue Market Share by Application (2016-2021)
Table 29. Global Female Contraceptives Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Female Contraceptives Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Female Contraceptives Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Female Contraceptives Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Female Contraceptives Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Female Contraceptives Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Female Contraceptives Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Female Contraceptives Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Female Contraceptives Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Female Contraceptives Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Female Contraceptives Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Female Contraceptives Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Female Contraceptives Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Female Contraceptives Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Female Contraceptives Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Female Contraceptives Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Female Contraceptives Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Female Contraceptives Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Female Contraceptives Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Female Contraceptives Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Female Contraceptives Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Female Contraceptives Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Female Contraceptives Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Female Contraceptives Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Female Contraceptives Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Female Contraceptives Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Female Contraceptives Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Female Contraceptives Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Female Contraceptives Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Female Contraceptives Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Female Contraceptives Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Female Contraceptives Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Female Contraceptives Product
Table 64. Bayer Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Mayer Laboratories Company Details
Table 67. Mayer Laboratories Business Overview
Table 68. Mayer Laboratories Female Contraceptives Product
Table 69. Mayer Laboratories Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 70. Mayer Laboratories Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Female Contraceptives Product
Table 74. Pfizer Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Mylan Company Details
Table 77. Mylan Business Overview
Table 78. Mylan Female Contraceptives Product
Table 79. Mylan Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 80. Mylan Recent Development
Table 81. Teva Company Details
Table 82. Teva Business Overview
Table 83. Teva Female Contraceptives Product
Table 84. Teva Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 85. Teva Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Female Contraceptives Product
Table 89. Merck Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Female Contraceptives Product
Table 94. Johnson & Johnson Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Lupin Pharmaceuticals Company Details
Table 97. Lupin Pharmaceuticals Business Overview
Table 98. Lupin Pharmaceuticals Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 99. Lupin Pharmaceuticals Recent Development
Table 100. Female Health Company Company Details
Table 101. Female Health Company Business Overview
Table 102. Female Health Company Female Contraceptives Product
Table 103. Female Health Company Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 104. Female Health Company Recent Development
Table 105. Fuji Latex Company Details
Table 106. Fuji Latex Business Overview
Table 107. Fuji Latex Female Contraceptives Product
Table 108. Fuji Latex Revenue in Female Contraceptives Business (2016-2021) & (US$ Million)
Table 109. Fuji Latex Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Contraceptives Market Share by Type: 2020 VS 2027
Figure 2. Contraceptive Drugs Features
Figure 3. Contraceptive Devices Features
Figure 4. Global Female Contraceptives Market Share by Application: 2020 VS 2027
Figure 5. Personal use Case Studies
Figure 6. Hospital Case Studies
Figure 7. Female Contraceptives Report Years Considered
Figure 8. Global Female Contraceptives Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Female Contraceptives Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Female Contraceptives Market Share by Regions: 2020 VS 2027
Figure 11. Global Female Contraceptives Market Share by Regions (2022-2027)
Figure 12. Global Female Contraceptives Market Share by Players in 2020
Figure 13. Global Top Female Contraceptives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Contraceptives as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Female Contraceptives Revenue in 2020
Figure 15. Global Female Contraceptives Revenue Market Share by Type (2016-2021)
Figure 16. Global Female Contraceptives Revenue Market Share by Type (2022-2027)
Figure 17. North America Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Female Contraceptives Market Share by Type (2016-2027)
Figure 19. North America Female Contraceptives Market Share by Application (2016-2027)
Figure 20. North America Female Contraceptives Market Share by Country (2016-2027)
Figure 21. United States Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Female Contraceptives Market Share by Type (2016-2027)
Figure 25. Europe Female Contraceptives Market Share by Application (2016-2027)
Figure 26. Europe Female Contraceptives Market Share by Country (2016-2027)
Figure 27. Germany Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Female Contraceptives Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Female Contraceptives Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Female Contraceptives Market Share by Region (2016-2027)
Figure 37. China Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Female Contraceptives Market Share by Type (2016-2027)
Figure 45. Latin America Female Contraceptives Market Share by Application (2016-2027)
Figure 46. Latin America Female Contraceptives Market Share by Country (2016-2027)
Figure 47. Mexico Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Female Contraceptives Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Female Contraceptives Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Female Contraceptives Market Share by Country (2016-2027)
Figure 53. Turkey Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Female Contraceptives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Bayer Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 57. Mayer Laboratories Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 59. Mylan Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 60. Teva Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 63. Lupin Pharmaceuticals Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 64. Female Health Company Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 65. Fuji Latex Revenue Growth Rate in Female Contraceptives Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Bayer、Mayer Laboratories、Pfizer、Mylan、Teva、Merck、Johnson & Johnson、Lupin Pharmaceuticals、Female Health Company、Fuji Latex

★調査レポート[世界の女性用避妊薬市場規模・現状・予測2021-2027] (コード:QY21APR2330)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の女性用避妊薬市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆